-
2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement A Report of the American College of Cardiology Solution Set Oversight CommitteeWriting Committee, SM Lilly, AJ Deshmukh et al. -
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al.
-
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II SurveyB Iung , V Delgado ,the EORP VHD II Investigators.
-
Infective endocarditis after transcatheter aortic valve implantation: a nationwide studyBjursten H, Rasmussen M, Nozohoor S et al.
-
Decline in Left Ventricular Ejection Fraction During Follow-Up in Patients With Severe Aortic StenosisE Minamino-Muta, T Kato, the CURRENT AS Registry Investigators et al.
-
Infective Endocarditis After Transcatheter Aortic Valve ReplacementS Stortecky, D Heg, D Tueller, T Pilgrim et al.
-
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical TrialMohamed Abdel-Wahab, M Landt, Franz-Josef Neumann
-
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and RegistriesH Gonzales, PS Douglas, BR Lindman et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
